• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, November 14, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Tiny ‘cages’ could keep vaccines safe at high temperatures

Bioengineer by Bioengineer
April 24, 2017
in Science News
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Vaccines and antibodies could be transported and stored without refrigeration by capturing them in tiny silica 'cages', a discovery which could make getting vital medicines to remote or dangerous places much easier, cheaper and safer.

Vaccines and many other medicines contain proteins which break down and become unusable at room temperatures, meaning they must be kept refrigerated for storage and transportation in a so-called "cold chain". Loss of vaccines through breaks in the cold chain are a serious global public health issue, in particular for mass childhood vaccination programmes in the developing world.

Breaks in cold chain storage result in the loss of millions of doses of vaccines each year.

But a University of Bath team, working with colleagues at the University of Newcastle, have created a technique which can keep proteins intact at high temperatures up to 100°C, by encasing them in silica cages. Silica, which sand is made from, is non-toxic and inert.

Once the protein has been encased in silica it can be stored or transported without refrigeration before the silica coat can be removed chemically, leaving the proteins unaffected.

The discovery means that vaccines and other important medicines could be transported much more easily, cheaply and safely, especially to remote areas or places lacking infrastructure where the need is often greatest.

The teams call their method ensilication and hope it will solve the costly and often impractical need for a cold chain to protect protein-based products including vaccines, antibodies and enzymes. The research is published in the journal Scientific Reports.

Dr Asel Sartbaeva from the University of Bath's Department of Chemistry, led the project. She said: "Once the proteins in a vaccine break down and tangle up, it's useless. You can think of it like an egg that's been boiled — it can't be unboiled.

"So the ability to store and transport proteins at room temperatures or even hotter would remove a major logistical problem for safely delivering vaccines and other medicines to patients around the world.

"We have demonstrated with ensilication that we can simply and reliably keep proteins from breaking down even at up to 100°C, or store them as a powder for up to three years at room temperature without loss of function.

"We're very excited by the potential applications of ensilication and our next steps will be to test our findings on more vaccines, antibodies, antiviral and anti-venom drugs and other biopharmaceuticals."

When a protein in solution is mixed with silica, silicon dioxide binds closely around protein to match its shape and quickly builds up many layers, encasing the protein. A major advantage of this method is that unlike similar techniques it doesn't require freeze-drying, something that around half of all vaccines won't survive intact.

A powder of ensilicated proteins results, and the silica cage enveloping the protein means it can be heated to 100°C or stored at 22°C for at least six months with no loss of function.

The research team tested the method on three proteins; one from a tetanus vaccine, horse haemoglobin and an enzyme from egg white.

###

The research was funded by The Royal Society, Annett Trust and the Alumni Fund at the University of Bath.

For further information, please contact Chris Melvin in the University of Bath Press Office on +44 (0)1225 383 941 or [email protected]

Photographs available at: http://bit.ly/2o3q16F

After 10am on 24th April the paper will be available at: http://www.nature.com/articles/srep46568 Draft copies available on request.

Watch Dr Sartbaeva deliver a Google X talk on thermally stable vaccines at: https://www.youtube.com/watch?v=PHD_rBfgZvw

Notes

The University of Bath celebrates its 50th anniversary this year as one of the UK's leading universities both in terms of research and our reputation for excellence in teaching, learning and graduate prospects.

In the REF 2014 research assessment 87 per cent of our research was defined as 'world-leading' or 'internationally excellent'. From making aircraft more fuel efficient, to identifying infectious diseases more quickly, or cutting carbon emissions through innovative building solutions, research from Bath is making a difference around the world.

Find out more: http://www.bath.ac.uk/research/

Well established as a nurturing environment for enterprising minds, Bath is ranked highly in all national league tables. We were chosen as the UK's top university in the Times Higher Education Student Experience Survey 2015.

Media Contact

Chris Melvin
[email protected]
44-012-253-83941
@uniofbath

http://www.bath.ac.uk

############

Story Source: Materials provided by Scienmag

Share12Tweet8Share2ShareShareShare2

Related Posts

Shifting Trends in Early-Onset Cancer Incidence

November 14, 2025

Understanding and Treating Obesity-Linked PCOS

November 14, 2025

Chlorella vulgaris Boosts Immune Response in Mice

November 14, 2025

Unlocking Unknown Chemicals with Pseudodata-Based Generation

November 14, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    318 shares
    Share 127 Tweet 80
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    210 shares
    Share 84 Tweet 53
  • New Research Unveils the Pathway for CEOs to Achieve Social Media Stardom

    201 shares
    Share 80 Tweet 50
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    142 shares
    Share 57 Tweet 36

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Shifting Trends in Early-Onset Cancer Incidence

Understanding and Treating Obesity-Linked PCOS

Chlorella vulgaris Boosts Immune Response in Mice

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 69 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.